Keywords: Eisai, US operations, Jb cutrs, Aricept

Eisai realigns US operations, with 20% job cuts

Article | 09 March 2011

Print This

Eisai Inc, a US subsidiary of Japan’s fourth-largest drugmaker Eisai (TYO: 4532), plans to realign its operations in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in